Printer Friendly
The Free Library
14,529,797 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Kobayashi Pharmaceutical Launches New Adult Acne Remedy 'Fukidia'.


Tokyo, Japan, Mar 17, 2006 - (JCN JCN Japan Corporate News
JCN Journal of Cognitive Neuroscience
JCN Journal of Cardiovascular Nursing
JCN Journal of Christian Nursing
JCN Job Control Number
JCN Journal of Child Neurology
JCN joint communications network (US DoD) 
) - On March 16, Kobayashi Pharmaceutical launched Fukidia, an over-the-counter (OTC OTC

See: Over-the-counter.


OTC

See over-the-counter market (OTC).
) drug for alleviating adult acne.

The new ointment, which contains ibuprofen ibuprofen (ī`byprō'fən), nonsteroidal anti-inflammatory drug (NSAID) that reduces pain, fever, and inflammation.  piconol as an active ingredient, helps suppress inflammation and prevent new pimples from forming.

One 10-gram unit sells for 1,000 yen (US $8.50).

Copyright [c] 2006 Japan Corporate News Network. All rights reserved.
COPYRIGHT 2006 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:JCNN News Summaries
Date:Mar 17, 2006
Words:62
Previous Article:Fukuoka Bank Adopts Hitachi's Finger Vien Authentication System for ATMs.
Next Article:Kobayashi Pharmaceutical Introduces New OTC Anemia Treatment.



Related Articles
Ortho sentenced for obstruction of justice. (Ortho Pharmaceutical Corp.)
THE BLEMISH BATTLE ADULT ACNE SUFFERERS SEEK RELIEF - AND ANSWERS.(U)
Kobayashi Pharmaceutical Announces Results for the Third Quarter Ended December 31, 2005.
Medical maverick Tsuneo Kobayashi: a forerunner of cancer treatment and prevention.
Kobayashi Pharmaceutical Sets up New Subsidiary in Germany.
Kobayashi Pharmaceutical Reports Financial Results for the Year Ended March 31, 2006.
Kobayashi Pharmaceutical to Market New Nutritional Supplement Product via Mail-Order.
Kobayashi Pharmaceutical Reports Financial Results for the First Quarter Ended June 30, 2006.
Kobayashi Pharmaceutical Reports Financial Results for the First Half Ended Sept. 30, 2006.
Kobayashi Pharmaceutical Reports Financial Results for the Year Ended March 31, 2007.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles